E-Mail
George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients. Final results indicating the lung protective effects of aspirin were published today in
Anesthesia & Analgesia. As we learned about the connection between blood clots and COVID-19, we knew that aspirin - used to prevent stroke and heart attack - could be important for COVID-19 patients, Jonathan Chow, MD, assistant professor of anesthesiology and critical care medicine and director of the Critical Care Anesthesiology Fellowship at the GW School of Medicine and Health Sciences, said. Our research found an association between low dose aspirin and decreased severity of COVID-19 and death.
E-Mail Two-thirds of 1,120 healthcare workers surveyed worldwide would separate mothers and babies with a positive or unknown COVID-19 status. Implementing Kangaroo Mother Care and keeping mothers and babies together could save more than 125,000 newborn lives, representing 65x decreased risk of newborn death compared to the risk of newborn deaths from COVID-19. New research underscores the need for decision-makers and providers, particularly in LMICs, to protect and strengthen care for small and sick newborns during the pandemic.
The COVID-19 pandemic is affecting the quality of care given to small and sick newborn babies in all regions of the world and threatening implementation of life-saving interventions, suggests new research published in
Credit: Sense Neuro Diagnostics
Sense Diagnostics announces initiation of clinical trial to evaluate a non-invasive brain scanner to monitor intracranial hemorrhage
SENSE device uses low-power tailored radio frequency (RF) pulse to detect changes that may indicate expanding brain bleed
Current standard of care lacks a means to monitor brain injury continuously, non-invasively, in real time, between CT scans
CINCINNATI, OH - March 16, 2021 - Sense Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, announced the initiation of a multicenter pivotal trial to evaluate the safety and efficacy of a non-invasive brain scanner to monitor intracranial hemorrhage (ICH) in an acute hospital setting. The SENSE device is a headset equipped with antennae that transmit a low-power tailored radio frequency (RF) pulse across the brain and uses an algorithm to detect signal changes that may indicate an expansion in ICH.
Credit: Getty images
SLOW walkers are almost four times more likely to die from COVID-19, and have over twice the risk of contracting a severe version of the virus, according to a team of researchers from the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre led by Professor Tom Yates at the University of Leicester. The study of 412,596 middle-aged UK Biobank participants examined the relative association of body mass index (BMI) and self-reported walking pace with the risk of contracting severe COVID-19 and COVID-19 mortality.
The analysis found slow walkers of a normal weight to be almost 2.5 times more likely to develop severe COVID-19 and 3.75 times more likely to die from the virus than normal weight fast walkers. (1)
E-Mail
In the last 20 years, Black adults living in rural areas of the United States experienced high mortality rates due to diabetes, high blood pressure, heart disease and stroke compared to white adults. According to a research letter published in the
Journal of the American College of Cardiology, racial disparities improved minimally in rural areas over the last two decades, with larger improvements occurring in urban areas. While modest gains have been made in reducing racial health inequities in urban areas, large gaps in death rates between Black and white adults persist in rural areas, particularly for diabetes and hypertension. We haven t meaningfully narrowed the racial gap in outcomes for these conditions in rural areas over the last two decades, said Rishi Wadhera, MD, MPP, MPhil, cardiologist at Beth Israel Deaconess Medical Center in Boston and senior author of the study. Given that diabetes, hypertension, and heart disease are preventable and treatable, target